Cyteir Therapeutics
ID: 5331571Cyteir Therapeutics is a rapid destruction of cancer cells founded in 2012 by Tim Romberger.
8
Funding Rounds
$253.1m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti* Ro******* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti***** Ro******* | - | - | - |
| Su*** M. Mo******* | - | - | |
| Je** Ge**** | - | - | - |
| Ma**** Re******* | - | - | - |
| Ra***** Br***** | - | - | - |
| Jo**** S. Za******** | - | - | - |
| Jo** Th*** | - | - | - |
| Je***** Hu****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cyteir Therapeutics has raised a total of $69.2m in funding over 8 rounds.
Key Insights:
- Cyteir Therapeutics , October 2019: $40.2m
- Cyteir Series B round, March 2018: $29m
- Cyteir Therapeutics funding round, March 2018: $29m
- Cyteir Therapeutics funding round, October 2019: $40.2m
- Cyteir Therapeutics Series C round February 2021: $80m
- Cyteir Therapeutics, Inc. funding round, March 2018: $29m
- Cyteir Therapeutics, Inc. funding round, December 2015: $5.72m
Industries
Cyteir Therapeutics is active in the following industries: